???The $101M #XPRIZEHealthspan competition is pushing boundaries to extend quality of life well into our later years.??? ? We’re grateful to have the support of Longevity Vision Fund Founder and XPRIZE Healthspan benefactor Sergey Young on this prize.? ? How will this competition help revolutionize aging?? ? ???Teams will develop therapeutics that target biological aging rather than disease.? ? ???The prize aims to improve human health before biological aging triggers the onset of chronic diseases and disabilities.? ? ???Moving toward proactive, holistic treatments that target the biology that leads to loss of function and health will decrease the prevalence of almost every chronic disease associated with aging. ? ???Teams will use a variety of therapeutic treatments - including but not limited to drugs, biologics, gene therapies, devices, nutritional or lifestyle approaches, administered either alone or in combination. ? Let’s make healthy aging possible for everyone. Learn more about XPRIZE Healthspan at?xprize.org/healthspan.
Longevity Vision Fund
风险投资与私募股权管理人
New York，New York 2,259 位关注者
We invest in longevity breakthroughs
关于我们
Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer, healthier lives. The fund’s mission is to accelerate longevity breakthroughs, and to make them accessible and affordable to everyone LVF provides venture funding (Series A-C / crossover) to health tech, longevity and biotech companies across the following sectors: - Therapeutic & Drug Delivery Platforms - Medical Technologies & Devices - Preventive Medicine & Early Diagnostics - Artificial Intelligence (AI) in Healthcare
- 网站
-
https://www.lvf.vc
Longevity Vision Fund的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 11-50 人
- 总部
- New York，New York
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
获取路线
555 Madison Avenue
5th floor
US，New York，New York，10022
Longevity Vision Fund员工
动态
-
The longevity cities panel at Milken Institute featuring Rajiv Ahuja, JD Jim Mellon of Juvenescence? , Tina Woods of Collider Health and Sergey Young of the Longevity Vision Fund ?? Very well attended! "We are the first cohort to benefit from the fundamental advances of geroscience" - Jim Mellon.
-
-
Longevity Vision Fund is proud to share that Eko Health, a portfolio company, has showcased a significant advancement at the American Heart Association Scientific Sessions 2023. Their AI-enabled digital stethoscope demonstrated over 2x the accuracy in detecting heart valve disease, with a 94.1% detection rate compared to the 41.2% detection rate of traditional stethoscopes. This innovation marks a crucial step forward in improving early detection and treatment of cardiac conditions. Link: https://lnkd.in/egfR3a25